FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

	As of September 30, 2024				Fair Value Measurements
			Fair		As of September 30, 2024
	Amount		Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	-	$	-	$	-	$	-	$	-
Note payable:
BroadOak loan		5,900		5,688		-		-		5,688
	$	5,900	$	5,688	$	-	$	-	$	5,688

(1) See Note 9, Other Accrued Expenses

	As of December 31, 2023				Fair Value Measurements
	Carrying		Fair		As of December 31, 2023
	Amount		Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	453	$	453	$	-	$	-	$	453
Note payable:
BroadOak loan		10,000		9,343		-		-		9,343
	$	10,453	$	9,796	$	-	$	-	$	9,796

(1) See Note 9, Other Accrued Expenses

SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability and BroadOak Loan to September 30, 2024 is as follows:

											Adjustment
											to Fair
	December 31, 2023		Payments			Transferred to Accrued Expenses			Accretion/Interest Accrued		Value/ Mark to Market		September 30, 2024
Asuragen	$	453	$	-		$	(487	)	$	34	$	-	$	-
BroadOak loans		9,343		(4,100	)		-			-		445		5,688
	$	9,796	$	(4,100	)	$	(487	)	$	34	$	445	$	5,688